Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Blue Ox Healthcare Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Blue Ox Healthcare Partners

Blue Ox Healthcare Partners

Operating

Blue Ox Healthcare Partners: A private investment firm specializing in growth-stage healthcare companies.

Location
New York City, NY, US
Founded
2008
Firm
Compare
Portfolio
Employees
Website

Blue Ox Healthcare Partners is a private investment firm that focuses on commercial growth-stage healthcare companies within the middle market. The firm typically invests in later-stage funding rounds, including Series A, D, E, F, and G, supporting companies that are scaling their operations and expanding their market presence.

Notable portfolio companies include Epic Sciences, Gemelli Biotech, and Sera Prognostics, which have collectively raised significant capital. The firm's investment philosophy centers on partnering with innovative healthcare enterprises to drive growth and improve patient outcomes. Blue Ox Healthcare Partners offers strategic guidance and industry expertise to its portfolio companies, leveraging the experience of its key partners and decision-makers to foster success.

Blue Ox Healthcare Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments6
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Series E2 (33.3%)
Series A1 (16.7%)
Series D1 (16.7%)
Series F1 (16.7%)
Series G1 (16.7%)

Stage Mix

Series E 33%Series A 17%Series D 17%Series F 17%Series G 17%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Epic Sciences logo

Epic Sciences

Gemelli Biotech logo

Gemelli Biotech

Sera Prognostics logo

Sera Prognostics

Blue Ox Healthcare Partners - Similar Investment Firms

Oxeon Partners logo

Oxeon Partners

oxeon.com

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

InnovaHealth Partners logo

InnovaHealth Partners

Signet Healthcare Partners logo

Signet Healthcare Partners

Galen Partners logo

Galen Partners

galen.com

Oxantium Ventures logo

Oxantium Ventures

oxantium.com

Octagon Capital Advisors logo

Octagon Capital Advisors

Regal Healthcare Capital Partners logo

Regal Healthcare Capital Partners

regalhcp.com

Health Enterprise Partners logo

Health Enterprise Partners

hepfund.com

Oxford Bioscience Partners logo

Oxford Bioscience Partners

kilbycream.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

EGS Healthcare Capital Partners logo

EGS Healthcare Capital Partners

Oceanic Partners logo

Oceanic Partners

oceanic.us

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

RoundTable Healthcare Partners logo

RoundTable Healthcare Partners

roundtablehp.com

Blue Ox Healthcare Partners - Classification

Also Known As
  • Blue Ox Healthcare Partners, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end